Infertility Treatment Market By Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Other Procedures) , By Patient Type (Female Infertility Treatment, Male Infertility Treatment) By End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 320 pages | ID: IDEF8BE0DC86EN
Allied Market Research

Abstracts

Infertility Treatment Market Expected to Garner $3.8 Billion by 2033, Growing at a CAGR of 8.6%

Abstract: The global infertility treatment market is expected to grow primarily due to the increasing acceptance of assisted reproductive technologies and the growing demand for genetic testing to prevent hereditary diseases. The Asia-Pacific region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global infertility treatment market was valued at $1.7 billion in 2023 and is expected to register a revenue of $3.8 billion by 2033 at a CAGR of 8.6% during the forecast period 2024-2033.

Dynamics of the Market

The increasing awareness & acceptance of assisted reproductive technologies, growing demand for genetic testing to prevent hereditary diseases, and policies promoting fertility treatments are expected to make the infertility treatment market a highly profitable one in the forecast period. Besides, lifestyle factors contributing to infertility, such as obesity & smoking are further boosting the market growth.

However, according to market analysts, legal restrictions on certain infertility treatments and disparities in access to reproductive healthcare services might restrain the growth of the market.

Technological innovations improving IVF outcomes and accessibility and advancements in third party IVF services present significant opportunities for infertility treatment market growth. Moreover, advancements in genomic testing are reducing genetic disorders during IVF, increasing its attractiveness on a global scale.

Key Players of the Market

The major players of the infertility treatment market include Thermo Fisher Scientific, Vitrolife, Cook Group, Baker Company INC., Genea Biomedx Ltd., Hamilton Thorne Ltd., Esco Micro Pte Ltd., FUJIFILM Irvine Scientific, and IVFtech APS.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• End user preferences and pain points
• Investment Opportunities
• Upcoming/New Entrant by Regions
• Technology Trend Analysis
• Consumer Preference and Product Specifications
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Strategic Recommendations
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Patient Type

• Female Infertility Treatment
• Male Infertility Treatment

By End User

• Fertility Centers
• Hospitals Surgical Clinics
• Cryobanks
• Research Institutes

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• Italy
• Spain
• UK
• France
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• UAE
• South Africa
• Rest of LAMEA

By Procedure

• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgeries
• Other Procedures
• Key Market Players
• Thermo Fisher Scientific Inc.
• Baker Company INC
• vitrolife
• Cook Group
• Genea Biomedx Ltd.
• Esco Micro Pte Ltd.
• Hamilton Thorne Ltd.
• FUJIFILM Irvine Scientific
• IVFtech ApS

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: INFERTILITY TREATMENT MARKET, BY PROCEDURE

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Procedure
4.2. Assisted Reproductive Technology
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Artificial Insemination
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Fertility Surgeries
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country
4.5. Other Procedures
  4.5.1. Key Market Trends, Growth Factors and Opportunities
  4.5.2. Market Size and Forecast, By Region
  4.5.3. Market Share Analysis, By Country

CHAPTER 5: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Patient Type
5.2. Female Infertility Treatment
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Male Infertility Treatment
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country

CHAPTER 6: INFERTILITY TREATMENT MARKET, BY END USER

6.1. Market Overview
  6.1.1 Market Size and Forecast, By End User
6.2. Fertility Centers
  6.2.1. Key Market Trends, Growth Factors and Opportunities
  6.2.2. Market Size and Forecast, By Region
  6.2.3. Market Share Analysis, By Country
6.3. Hospitals Surgical Clinics
  6.3.1. Key Market Trends, Growth Factors and Opportunities
  6.3.2. Market Size and Forecast, By Region
  6.3.3. Market Share Analysis, By Country
6.4. Cryobanks
  6.4.1. Key Market Trends, Growth Factors and Opportunities
  6.4.2. Market Size and Forecast, By Region
  6.4.3. Market Share Analysis, By Country
6.5. Research Institutes
  6.5.1. Key Market Trends, Growth Factors and Opportunities
  6.5.2. Market Size and Forecast, By Region
  6.5.3. Market Share Analysis, By Country

CHAPTER 7: INFERTILITY TREATMENT MARKET, BY REGION

7.1. Market Overview
  7.1.1 Market Size and Forecast, By Region
7.2. North America
  7.2.1. Key Market Trends and Opportunities
  7.2.2. Market Size and Forecast, By Procedure
  7.2.3. Market Size and Forecast, By Patient Type
  7.2.4. Market Size and Forecast, By End User
  7.2.5. Market Size and Forecast, By Country
  7.2.6. U.S. Infertility Treatment Market
    7.2.6.1. Market Size and Forecast, By Procedure
    7.2.6.2. Market Size and Forecast, By Patient Type
    7.2.6.3. Market Size and Forecast, By End User
  7.2.7. Canada Infertility Treatment Market
    7.2.7.1. Market Size and Forecast, By Procedure
    7.2.7.2. Market Size and Forecast, By Patient Type
    7.2.7.3. Market Size and Forecast, By End User
  7.2.8. Mexico Infertility Treatment Market
    7.2.8.1. Market Size and Forecast, By Procedure
    7.2.8.2. Market Size and Forecast, By Patient Type
    7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
  7.3.1. Key Market Trends and Opportunities
  7.3.2. Market Size and Forecast, By Procedure
  7.3.3. Market Size and Forecast, By Patient Type
  7.3.4. Market Size and Forecast, By End User
  7.3.5. Market Size and Forecast, By Country
  7.3.6. Germany Infertility Treatment Market
    7.3.6.1. Market Size and Forecast, By Procedure
    7.3.6.2. Market Size and Forecast, By Patient Type
    7.3.6.3. Market Size and Forecast, By End User
  7.3.7. Italy Infertility Treatment Market
    7.3.7.1. Market Size and Forecast, By Procedure
    7.3.7.2. Market Size and Forecast, By Patient Type
    7.3.7.3. Market Size and Forecast, By End User
  7.3.8. Spain Infertility Treatment Market
    7.3.8.1. Market Size and Forecast, By Procedure
    7.3.8.2. Market Size and Forecast, By Patient Type
    7.3.8.3. Market Size and Forecast, By End User
  7.3.9. UK Infertility Treatment Market
    7.3.9.1. Market Size and Forecast, By Procedure
    7.3.9.2. Market Size and Forecast, By Patient Type
    7.3.9.3. Market Size and Forecast, By End User
  7.3.10. France Infertility Treatment Market
    7.3.10.1. Market Size and Forecast, By Procedure
    7.3.10.2. Market Size and Forecast, By Patient Type
    7.3.10.3. Market Size and Forecast, By End User
  7.3.11. Rest Of Europe Infertility Treatment Market
    7.3.11.1. Market Size and Forecast, By Procedure
    7.3.11.2. Market Size and Forecast, By Patient Type
    7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
  7.4.1. Key Market Trends and Opportunities
  7.4.2. Market Size and Forecast, By Procedure
  7.4.3. Market Size and Forecast, By Patient Type
  7.4.4. Market Size and Forecast, By End User
  7.4.5. Market Size and Forecast, By Country
  7.4.6. China Infertility Treatment Market
    7.4.6.1. Market Size and Forecast, By Procedure
    7.4.6.2. Market Size and Forecast, By Patient Type
    7.4.6.3. Market Size and Forecast, By End User
  7.4.7. Japan Infertility Treatment Market
    7.4.7.1. Market Size and Forecast, By Procedure
    7.4.7.2. Market Size and Forecast, By Patient Type
    7.4.7.3. Market Size and Forecast, By End User
  7.4.8. India Infertility Treatment Market
    7.4.8.1. Market Size and Forecast, By Procedure
    7.4.8.2. Market Size and Forecast, By Patient Type
    7.4.8.3. Market Size and Forecast, By End User
  7.4.9. South Korea Infertility Treatment Market
    7.4.9.1. Market Size and Forecast, By Procedure
    7.4.9.2. Market Size and Forecast, By Patient Type
    7.4.9.3. Market Size and Forecast, By End User
  7.4.10. Australia Infertility Treatment Market
    7.4.10.1. Market Size and Forecast, By Procedure
    7.4.10.2. Market Size and Forecast, By Patient Type
    7.4.10.3. Market Size and Forecast, By End User
  7.4.11. Rest of Asia-Pacific Infertility Treatment Market
    7.4.11.1. Market Size and Forecast, By Procedure
    7.4.11.2. Market Size and Forecast, By Patient Type
    7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
  7.5.1. Key Market Trends and Opportunities
  7.5.2. Market Size and Forecast, By Procedure
  7.5.3. Market Size and Forecast, By Patient Type
  7.5.4. Market Size and Forecast, By End User
  7.5.5. Market Size and Forecast, By Country
  7.5.6. Brazil Infertility Treatment Market
    7.5.6.1. Market Size and Forecast, By Procedure
    7.5.6.2. Market Size and Forecast, By Patient Type
    7.5.6.3. Market Size and Forecast, By End User
  7.5.7. Saudi Arabia Infertility Treatment Market
    7.5.7.1. Market Size and Forecast, By Procedure
    7.5.7.2. Market Size and Forecast, By Patient Type
    7.5.7.3. Market Size and Forecast, By End User
  7.5.8. UAE Infertility Treatment Market
    7.5.8.1. Market Size and Forecast, By Procedure
    7.5.8.2. Market Size and Forecast, By Patient Type
    7.5.8.3. Market Size and Forecast, By End User
  7.5.9. South Africa Infertility Treatment Market
    7.5.9.1. Market Size and Forecast, By Procedure
    7.5.9.2. Market Size and Forecast, By Patient Type
    7.5.9.3. Market Size and Forecast, By End User
  7.5.10. Rest of LAMEA Infertility Treatment Market
    7.5.10.1. Market Size and Forecast, By Procedure
    7.5.10.2. Market Size and Forecast, By Patient Type
    7.5.10.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Thermo Fisher Scientific Inc.
  9.1.1. Company Overview
  9.1.2. Key Executives
  9.1.3. Company Snapshot
  9.1.4. Operating Business Segments
  9.1.5. Product Portfolio
  9.1.6. Business Performance
  9.1.7. Key Strategic Moves and Developments
9.2. Baker Company INC
  9.2.1. Company Overview
  9.2.2. Key Executives
  9.2.3. Company Snapshot
  9.2.4. Operating Business Segments
  9.2.5. Product Portfolio
  9.2.6. Business Performance
  9.2.7. Key Strategic Moves and Developments
9.3. Vitrolife
  9.3.1. Company Overview
  9.3.2. Key Executives
  9.3.3. Company Snapshot
  9.3.4. Operating Business Segments
  9.3.5. Product Portfolio
  9.3.6. Business Performance
  9.3.7. Key Strategic Moves and Developments
9.4. Cook Group
  9.4.1. Company Overview
  9.4.2. Key Executives
  9.4.3. Company Snapshot
  9.4.4. Operating Business Segments
  9.4.5. Product Portfolio
  9.4.6. Business Performance
  9.4.7. Key Strategic Moves and Developments
9.5. Genea Biomedx Ltd.
  9.5.1. Company Overview
  9.5.2. Key Executives
  9.5.3. Company Snapshot
  9.5.4. Operating Business Segments
  9.5.5. Product Portfolio
  9.5.6. Business Performance
  9.5.7. Key Strategic Moves and Developments
9.6. Esco Micro Pte Ltd.
  9.6.1. Company Overview
  9.6.2. Key Executives
  9.6.3. Company Snapshot
  9.6.4. Operating Business Segments
  9.6.5. Product Portfolio
  9.6.6. Business Performance
  9.6.7. Key Strategic Moves and Developments
9.7. Hamilton Thorne Ltd.
  9.7.1. Company Overview
  9.7.2. Key Executives
  9.7.3. Company Snapshot
  9.7.4. Operating Business Segments
  9.7.5. Product Portfolio
  9.7.6. Business Performance
  9.7.7. Key Strategic Moves and Developments
9.8. FUJIFILM Irvine Scientific
  9.8.1. Company Overview
  9.8.2. Key Executives
  9.8.3. Company Snapshot
  9.8.4. Operating Business Segments
  9.8.5. Product Portfolio
  9.8.6. Business Performance
  9.8.7. Key Strategic Moves and Developments
9.9. IVFtech ApS
  9.9.1. Company Overview
  9.9.2. Key Executives
  9.9.3. Company Snapshot
  9.9.4. Operating Business Segments
  9.9.5. Product Portfolio
  9.9.6. Business Performance
  9.9.7. Key Strategic Moves and Developments